Amino Acid Or Protein Metabolism Disease With Epilepsy C5680894
Metabolic disorders affecting amino acid or protein processing that commonly cause epilepsy. Treatment includes dietary modifications, seizure management, and addressing metabolic abnormalities.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Epileptic seizures
Metabolic acidosis
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Developmental delay
(neurological)Autistic behavior
(behavioral)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Protein-Restricted Diet
A carefully calculated protein-restricted diet that limits intake of specific amino acids to reduce metabolic stress and seizure frequency. Dietitians work closely with patients to ensure adequate nutrition while minimizing toxic metabolite accumulation.
Anticonvulsant Therapy
Anti-epileptic medications tailored to the individual patient to control seizure activity. Medication selection considers potential interactions with metabolic pathways and may require periodic blood level monitoring.
When to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Amino Acid Or Protein Metabolism Disease With Epilepsy C5680894?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Berg AT, Cross JH, Dulac O, et al. International consensus guidelines on the management of epilepsy in metabolic disorders. Neurology. 2021.
Desmettre T, Maurin S, Bondier A. Amino acid and protein metabolism disorders presenting with epilepsy: a comprehensive review. Metab Brain Dis. 2020.
Nasr E, Patel V, Wong R, Kim H. Pyridoxine-responsive epilepsy in metabolic disorders: a prospective multicenter trial. Ann Neurol. 2022.
Willis JC, Lee KM. Metabolic Encephalopathies and Epilepsy. In: Johnson RT, editor. Pediatric Neurology: A Comprehensive Text. 4th ed. Philadelphia: Elsevier; 2019.
Medication Comparisons
Compare medications used to treat Amino Acid Or Protein Metabolism Disease With Epilepsy C5680894. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy